Fig. 5From: MYC drives platinum resistant SCLC that is overcome by the dual PI3K-HDAC inhibitor fimepinostatFimepinostat reduces MYC expression. Western blot analysis showing reduction in MYC expression, phosphorylated (S473) AKT and increased acetylation of histone H3 following a 24-h treatment with the indicated dose of fimepinostat in platinum resistance mouse SCLC cell lines (A) B37R and (B) EN84RBack to article page